MARTIN DANIEL C. (Chief Commercial Officer) sold 4.0% of their position (2.27K shares) of DECIPHERA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $35.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2024ACC: 0000950170-24-017087
Officer· Chief Commercial Officer
Since Sep 2018
+46.36K
Net shares
Net buyer
$35.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
48.63K acquired · 2.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.72K
Price / share
—
Trade value
—
% of position
20.4%
2/15/2024
47.66K→57.38K
Common Stock
Direct
Shares
−2.27K
Price / share
$15.62
Trade value
$35.41K
% of position
4.0%
2/16/2024
57.38K→55.12K
Total
Net shares
+7.46K
Net value
-$35.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2024 | A · Award | +9.72K | — | — | 20.4% | 47.66K | 57.38K |
| Common Stock Direct | 2/16/2024 | S · Sale | −2.27K | $15.62 | $35.41K | 4.0% | 57.38K | 55.12K |
| Total | +7.46K | -$35.41K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
38.90K shares
Shares
+38.90K
Strike price
15.92
Held after
38.90K
Exercisable
—
2/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock38.90K shares | 2/15/2024 | A · Award | +38.90K | 15.92 | — | 38.90K |